- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Silibinin-C-2',3-dihydrogensuccinate, disodium salt
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Silibinin-C-2',3-dihydrogensuccinate, disodium salt
| EU orphan designation number: | EU/3/10/828
|
| Active ingredient: | Silibinin-C-2',3-dihydrogensuccinate, disodium salt |
| Indication: | Prevention of recurrent hepatitis C in liver transplant recipients |
| Sponsor: | Rottapharm S.p.A
Galleria Unione, 5, 20122 Milan, Italia |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 23/12/2010 | Orphan designation | EMA/OD/103/10 | (2010)9541 of 17/12/2010 |
CONTACT
EU links
Directorate General Health & Consumers